Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT).
Phase of Trial: Phase II/III
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Alteplase (Primary) ; Urokinase (Primary) ; Heparin
- Indications Intracranial thrombosis
- Focus Therapeutic Use
- Acronyms TO-ACT; TOACT
- 11 Feb 2017 Planned End Date changed from 1 Jan 2018 to 1 Oct 2017.
- 11 Feb 2017 Status changed from recruiting to discontinued.
- 08 Nov 2011 New source identified and integrated (European Clinical Trials Database: EudraCT2010-020302-15).